Erlotero 150 Mg Erlotinib Tablets About
Erlotero 150 Mg Erlotinib Tablets are a top-rated and advanced prescription medicine renowned for its effectiveness in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Each lustrous white tablet contains 150 mg of celebrated Erlotinib Hydrochloride, an EGFR inhibitor, designed for oral administration. Formulated to the highest IP standards, Erlotero-150 ensures best price options for those seeking quality oncological care. Packaged in a secure blister pack of 1x30 tablets, this medicine is manufactured in India and comes with bilingual labeling, making it accessible and trusted worldwide.
Application and Competitive Advantages of Erlotero-150
Erlotero 150 Mg Erlotinib Tablets are used primarily for the treatment of advanced cancers, specifically NSCLC and pancreatic cancer in adults. This celebrated formulation offers a competitive advantage due to its high purity, IP grade compliance, and top-rated efficacy. Its application through oral administration provides convenience and consistent dosing, making it suitable for daily use under physician guidance. The tablet form ensures measured delivery in a variety of clinical settings, enhancing adherence and patient outcomes.
Shipping, Packaging, and Sample Policy for Erlotero-150
Erlotero 150 Mg Erlotinib Tablets are shipped globally from major Indian FOB ports in securely sealed boxes, each containing a blister pack of 30 tablets. The packaging resists moisture and light, preserving potency throughout the product's lifespan. Sample exchange and policy details are transparently outlined for qualifying orders, ensuring low outlay for initial evaluation. Customers can request product samples where applicable, with all shipping and sample specifics adhering to standard pharmaceutical trade protocols.
FAQ's of Erlotero 150 Mg Erlotinib Tablets:
Q: How should Erlotero 150 Mg Erlotinib Tablets be taken for optimal results?
A: Erlotero 150 Mg Erlotinib Tablets should be taken orally once daily or as prescribed by your physician, without crushing or chewing the tablet. Adherence to the recommended dosage schedule is vital for optimal therapeutic benefit.
Q: What are the primary indications for using Erlotero-150?
A: Erlotero-150 is primarily indicated for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer, helping to inhibit cancer cell growth effectively.
Q: Where is Erlotero-150 manufactured and what quality standards does it meet?
A: Erlotero-150 is manufactured in India and is compliant with IP 150 mg grade standards, ensuring high quality and consistency for patient use.
Q: What is the process for obtaining Erlotero 150 Mg Erlotinib Tablets?
A: Erlotero 150 can be obtained through a valid prescription from licensed pharmacies or healthcare providers, with all purchase details and expiry information clearly marked on the packaging.
Q: When should the storage conditions for Erlotero-150 be considered?
A: Erlotero-150 should always be stored below 30C, protected from light and moisture, to maintain its effectiveness up to the expiration date indicated on the box.
Q: What benefits does the blister pack offer for Erlotero 150 Mg Erlotinib Tablets?
A: The blister packaging maintains the stability and integrity of each tablet until use, offering convenience, safety, and accurate dosage for each administration.